MondayMar 28, 2022 9:00 am

Delic Holdings Corp’s (CSE: DELC) (OTCQB: DELCF) Co-Founder and CEO Offers a Glimpse into the Company’s History and Future on The Jesse Tee Show

While appearing on The Jesse Tee Show, the company’s co-founder and CEO, Matt Stang, shared his professional background, Delic’s history, its growth, and its plans going forward Mr. Stang attributes its success to understanding where opportunities and people connect, how to make things win-win for all people, and giving customers value Founded in 2016, Delic Holdings Corp now has a market cap of $4.32 million as of March 2022 Delic Holdings (CSE: DELC) (OTCQB: DELCF) has been at the forefront of reframing the psychedelic conversation. It has also remained committed to bringing science-backed benefits of psychedelics to the health industry,…

Continue Reading

FridayMar 25, 2022 9:00 am

Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Makes Psychedelic Treatment More Accessible with Opening of New Reno Clinic

Following the acquisition of KWC back in November 2021, Delic Holdings Corp set out to open additional state-of-the-art ketamine infusion treatment clinics over the course of 18 months The company has just announced the opening of its second clinic in Nevada in a move that will serve both local patients and those in larger California markets without access to affordable in-state providers Delic is still set to open more clinics over the course of the next 18 months in a move that seeks to expand access to reasonably priced treatments for various mental health conditions In November 2021, Delic Holdings…

Continue Reading

WednesdayMar 23, 2022 1:54 pm

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Participating, Presenting at Upcoming Investor Conferences

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, will be represented at three upcoming events: the Scottsdale Capital Event, Planet MicroCap Showcase and H.C. Wainwright Annual Global Life Sciences Conference. Delic CEO and cofounder Matt Stang will present at each event, including providing an outline of the company’s strategic outlook; he  will also be available for one-on-one meetings at each event. Hosted by Capital Event Management, the Scottsdale Capital Event is scheduled for April 22–24, 2022. This event is designed to connect growing companies with premier financiers through meetings and…

Continue Reading

MondayMar 21, 2022 1:42 pm

QualityStocksNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) Scalable Approach to Psychedelic-Based Treatments Aimed at ‘Giving People Their Best Selves Back’

Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, aims to help people live better lives through the largest ketamine clinic chain in the United States, Ketamine Wellness Centers (“KWC”). The chain operates in multiple locations, strategically located in secondary cities to improve accessibility and reach and serve the greatest number of patients. In addition, the company’s scientific backbone, DELIC Labs, is a federally authorized psilocybin and cannabis research laboratory that dedicates its efforts to improving extraction, analytical testing and chemical processes. The lab’s R&D solutions for product lines and new intellectual property (“IP”) serve as the engine…

Continue Reading

ThursdayMar 17, 2022 11:49 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO, Cofounder Featured on the Jesse Tee Show Interview

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, and company CEO and cofounder Matt Stang were spotlighted during a recent segment of the Jesse Tee Show. During the interview, Stang provided a summary of the journey to his present position with Delic Holdings, noting that he started as an intern with “High Times.” He worked in several positions at the publication, eventually buying out one of the owners. Stang also discussed the therapeutic potential of psychedelic compounds and provided a brief history of Delic. “In 2016, we put ‘High Times’ up…

Continue Reading

ThursdayMar 17, 2022 9:15 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Aiming to Reach Millions of Mental Health Patients with Effective, Affordable Ketamine Treatments

Mental health conditions affect millions of people globally, some of whom are resistant to existing treatments In the early 1990s, Yale researchers discovered that ketamine offered immediate relief to chronically depressed patients, and since then, the scientists have continually investigated the compound’s role in mental health treatment Delic’s subsidiary, Ketamine Wellness Centers, notes that ketamine is now extensively used for multiple treatment-resistant mental conditions, with patient outcomes showing its therapeutic effectiveness Delic hopes to reach millions of people suffering from various mental health conditions who have lost hope of finding effective, affordable treatments The World Health Organization (“WHO”) reports that…

Continue Reading

WednesdayMar 16, 2022 11:30 am

QualityStocksNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Subsidiary Expands Footprint with Opening of Reno Clinic

Delic Holdings’ (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) subsidiary, Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S., has expanded its presence within the state of Nevada with the opening of its Reno location. According to the announcement, KWC Reno is the second of the company's clinics to open in Nevada within the last 18 months, bringing the total number of KWC clinics to 13 across nine states. The 2,200-square-foot treatment facility will serve local patients while also opening its doors to patients in larger California markets who do not have access to affordable in-state providers. “With…

Continue Reading

WednesdayMar 16, 2022 9:00 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Leverages Research to Promote Mental Health

Delic Holdings Corp, a leader in new medicines and treatments for a modern world, understands that research is integral for both the rapidly developing psychedelics and cannabis industries, and for psychedelics to be widely adopted for the treatment of mental health issues Dr. Markus Roggen, President and CSO of Delic Labs, recently spoke at this year’s Emerald Conference, and has reiterated the importance of leveraging AI in crafting products for the cannabis industry Delic is continually expanding its efforts to conduct and encourage even more research and education in support of high-quality products for more people, supporting mental health while…

Continue Reading

WednesdayMar 09, 2022 2:05 pm

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Seeking to Tap Potential of Emerging Psychedelics in Health Care Space

Delic Holdings (CSE: DELC) (OTCQB: DELCF) understands the potential of the psychedelic industry in regard to health care. While in its early stages, the industry is estimated to grow tremendously, and Delic seeks to capitalize on the sector’s potential to not only benefit millions of people dealing with mental health issues, but also create value for its shareholders. “Delic is banking on scientific research to prove the usefulness and effectiveness of psychedelics as an alternative treatment for specific mental health conditions. It also relies on customer feedback to help push the conversation and further increase the sensitization of psychedelics for…

Continue Reading

WednesdayMar 02, 2022 3:03 pm

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Pushing for Adoption of and Wider Access to Psychedelic-Based Treatments

Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, recognizes the opportunity within the mental health treatment space and acknowledges the underlying issues affecting people living with these conditions, especially in the United States. Here, over 51.5 million people have experienced a mental health condition, with figures rising because of the pandemic. “As a leader in new medicines and treatments for the modern world, the company is pushing for psychedelic-based treatment adoptions and access to an even wider pool of individuals who could benefit significantly from these treatments,” a recent article reads. In acknowledging the lack of access…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered